AbbVie SEC Filings & 10K Form

$116.25
+0.80 (+0.69 %)
(As of 08/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$114.89
$116.31
50-Day Range
$111.40
$118.87
52-Week Range
$79.11
$119.15
Volume5.89 million shs
Average Volume6.84 million shs
Market Capitalization$205.32 billion
P/E Ratio31.33
Dividend Yield4.47%
Beta0.82

AbbVie (NYSE:ABBV) SEC Filings

DateFilerForm TypeView
08/02/2021
12:28 PM
AbbVie (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2021
6:52 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/26/2021
4:20 PM
AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2021
4:12 PM
AbbVie (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/11/2021
4:07 PM
AbbVie (Issuer)
WADDELL FREDERICK H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:07 PM
AbbVie (Issuer)
TILTON GLENN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:07 PM
AbbVie (Issuer)
Roberts Rebecca B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:06 PM
AbbVie (Issuer)
RAPP EDWARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:06 PM
AbbVie (Issuer)
MEYER MELODY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:06 PM
AbbVie (Issuer)
Hart Brett J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:06 PM
AbbVie (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:05 PM
AbbVie (Issuer)
FREYMAN THOMAS C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:05 PM
AbbVie (Issuer)
BURNSIDE WILLIAM H.L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:05 PM
AbbVie (Issuer)
AUSTIN ROXANNE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:05 PM
AbbVie (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:05 PM
AbbVie (Issuer)
Strom Carrie C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
9:14 AM
AbbVie (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2021
2:39 PM
AbbVie (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
Form 25-NSE
04/30/2021
6:44 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2021
7:30 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2021
12:10 PM
AbbVie (Subject)
ZEVIN ASSET MANAGEMENT LLC (Filed by)
Form PX14A6G
04/01/2021
3:43 PM
AbbVie (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
3:43 PM
AbbVie (Issuer)
LIDDY EDWARD M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
3:43 PM
AbbVie (Issuer)
RAPP EDWARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2021
1:18 PM
AbbVie (Subject)
Rhode Island Employees Retirement System Pool Trust (Filed by)
Form PX14A6G
03/29/2021
9:56 AM
AbbVie (Subject)
Chevedden John (Filed by)
Form PX14A6G
03/22/2021
4:03 PM
AbbVie (Filer)
Form DEFA14A
03/12/2021
4:02 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2021
4:26 PM
AbbVie (Issuer)
Strom Carrie C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
4:27 PM
AbbVie (Filer)
Form PRE 14A
03/02/2021
7:34 PM
AbbVie (Issuer)
Gosebruch Henry O (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:32 PM
AbbVie (Issuer)
Michael Robert A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:31 PM
AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:31 PM
AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:30 PM
AbbVie (Issuer)
Sorg Elaine K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:29 PM
AbbVie (Issuer)
Durkin Brian L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:29 PM
AbbVie (Issuer)
Hudson Thomas J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:27 PM
AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:26 PM
AbbVie (Issuer)
Stewart Jeffrey Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:26 PM
AbbVie (Issuer)
SEVERINO MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:25 PM
AbbVie (Issuer)
Schumacher Laura J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:25 PM
AbbVie (Issuer)
Strom Carrie C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2021
5:28 PM
AbbVie (Issuer)
Sorg Elaine K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:25 PM
AbbVie (Issuer)
Gosebruch Henry O (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:25 PM
AbbVie (Issuer)
Michael Robert A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:23 PM
AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:23 PM
AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:23 PM
AbbVie (Issuer)
SEVERINO MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:19 PM
AbbVie (Issuer)
Stewart Jeffrey Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:19 PM
AbbVie (Issuer)
Schumacher Laura J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:18 PM
AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:17 PM
AbbVie (Issuer)
Hudson Thomas J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:17 PM
AbbVie (Issuer)
Sorg Elaine K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:16 PM
AbbVie (Issuer)
Strom Carrie C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:15 PM
AbbVie (Issuer)
Durkin Brian L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
1:05 PM
AbbVie (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/16/2021
2:46 PM
AbbVie (Subject)
Capital Research Global Investors (Filed by)
Form SC 13G/A
02/03/2021
6:41 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2021
3:30 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2021
4:00 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2020
12:15 PM
AbbVie (Issuer)
Stewart Jeffrey Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2020
12:14 PM
AbbVie (Issuer)
Schumacher Laura J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2020
12:13 PM
AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:34 PM
AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:31 PM
AbbVie (Issuer)
Stewart Jeffrey Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2020
4:22 PM
AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2020
4:34 PM
AbbVie (Issuer)
Gosebruch Henry O (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2020
3:20 PM
AbbVie (Filer)
Form CERT
11/20/2020
3:05 PM
AbbVie (Filer)
Form 8-A12B
11/19/2020
3:48 PM
AbbVie (Issuer)
Sorg Elaine K. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/18/2020
4:16 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2020
4:04 PM
AbbVie (Issuer)
ALBAN CARLOS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2020
4:56 PM
AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2020
4:55 PM
AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
Form 4/A
11/12/2020
4:54 PM
AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2020
9:05 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2020
3:29 PM
AbbVie (Issuer)
SEVERINO MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2020
3:29 PM
AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
8:53 AM
AbbVie (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2020
6:52 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2020
8:13 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2020
7:00 AM
AbbVie (Filer)
Form 424B3
10/18/2020
11:15 PM
AbbVie (Filer)
Form EFFECT
10/02/2020
3:52 PM
AbbVie (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
3:52 PM
AbbVie (Issuer)
LIDDY EDWARD M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
3:05 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2020
8:55 AM
AbbVie (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2020
3:57 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2020
8:19 PM
AbbVie (Issuer)
ALBAN CARLOS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
8:32 AM
AbbVie (Issuer)
RAPP EDWARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
8:28 AM
AbbVie (Issuer)
LIDDY EDWARD M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
8:26 AM
AbbVie (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
4:01 PM
AbbVie (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/18/2020
4:00 PM
AbbVie (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/01/2020
4:01 PM
AbbVie (Filer)
Form SD
Specialized Disclosure Report  
05/22/2020
4:47 PM
AbbVie (Issuer)
FREYMAN THOMAS C (Reporting)
Form 4/A
05/22/2020
4:46 PM
AbbVie (Issuer)
FREYMAN THOMAS C (Reporting)
Form 3/A
05/14/2020
4:00 PM
AbbVie (Filer)
Form 8-K/A
05/14/2020
3:16 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2020
4:54 PM
AbbVie (Issuer)
FREYMAN THOMAS C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 8/4/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.